Cigna scoops up Humana Medicare Advantage plans
Sale of plans in three Texas and Arkansas markets will help Humana satisfy its government-stipulated divestiture so that it can complete its acquisition of Arcadian Health.
Cigna will purchase Medicare Advantage plans in three markets in Texas and Arkansas from Humana. The sale comes on the heels of last year’s government stipulation that Humana divest some of its Medicare Advantage plans in order to complete its acquisition of Arcadian Health.
The plans in Amarillo and Longview-Marshall, Texas, and Texarkana, Ark., will move about 3,500 Humana or Arcadian members to Cigna’s HealthSpring on Jan. 1, 2013. HealthSpring, based in Nashville, already serves more than 1 million customers, but this allows it to extend into Arkansas for the first time and expand its current footprint in Texas.
“We welcome our new customers to our talented team of doctors and staff that have proudly served our customers for over a decade,” stated HealthSpring President Herb Fritch in a press release. “At HealthSpring, we dedicate significant resources to meet the individual needs of each and every one of our customers and we look forward to delivering our service to more Texas and Arkansas seniors.”
Go back to the Managed Healthcare Executive eNews newsletter.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More
